Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

PyroGenesis Announces Creation of “PyroGenesis Additive”: Division Dedicated to Additive Manufacturing and First Step to Spin-off; Provides General Up $PYR.ca

Posted by AGORACOM-JC at 9:30 AM on Wednesday, June 14th, 2017

Pyr header 1

  • Created a new division under the name of “PyroGenesis Additive“, dedicated solely to PyroGenesis’ additive manufacturing business line
  • First step to the Company’s previously announced strategic spin-off

MONTREAL, QUEBEC–(June 14, 2017) – PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX VENTURE:PYR)(OTCQB:PYRNF), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma waste-to-energy systems and plasma torch products, is pleased to announce today that it has created a new division under the name of “PyroGenesis Additive“, dedicated solely to PyroGenesis‘ additive manufacturing business line. This is the first step to the Company’s previously announced strategic spin-off.

PyroGenesis is the inventor of Plasma Atomization, using this process to produce very small, uniform, fully dense and spherical metal powders that flow like water, and which are highly sought after in the additive manufacturing (“AM”) Industry.

The Company first began producing powders using Plasma Atomization for the biomedical industry between 2001-2004. In 2015, PyroGenesis invested approximately $2MM in improving both the production rate and particle size distribution, which led not only to a patent pending, but also to PyroGenesis’ decision to re-enter the market and produce powders for the AM Industry.

The following highlights and developments have been made to date:

  • On October 26, 2015, PyroGenesis announced that it was re-entering the market to produce metal powders, specifically for AM (3D printing);
  • On April 7, 2016, PyroGenesis announced its intention to spin-off its additive manufacturing capabilities into an independent public entity;
  • On April 27, 2016, PyroGenesis announced that its 3D metal particle size distribution greatly exceeded expectations;
  • On October 25, 2016, PyroGenesis announced that it had filed a patent for an improved metal powder production process and that the Company was on schedule for a 2017-Q1 assembly and first production run;
  • On January 23 and March 14, 2017, PyroGenesis provided updates and reaffirms that it is on schedule for 2017-Q1 assembly and first production run despite delays with suppliers;
  • On March 30, 2017, PyroGenesis announced that it had completed the assembly of its first powder production system, with its first powder run exceeding expectations. The Company also noted that the ramp-up, which was already underway, was expected to take place linearly over approximately four (4) months;
  • On April 25, 2017, PyroGenesis announced receipt of its first powder order from a multinational conglomerate, with the down payment already received, and market interest exceeding expectations; and
  • On June 7, 2017, PyroGenesis announced receipt of its second powder order.

The current production system is the first of many PyroGenesis expects to make to address an increasing need for metal powders in the AM Industry.1

Mr. P. Peter Pascali, President and CEO of PyroGenesis, provides an update on the developments within PyroGenesis’ AM business line in the following Q&A format:

Q. Very very busy year so far for PyroGenesis and now we see the creation of PyroGenesis Additive.

A. Most definitely. Over the top. Exceeds our wildest expectations on every front.

Q. So are we finally going to see some movement with respect to the spin-off announced in April 2016?

A. Most certainly. The creation of PyroGenesis Additive is definitely the first step in spinning off our AM capabilities, which we announced over a year ago, into a standalone entity. We are dedicated to a spin-off for a number of reasons, all of which speak to increasing shareholder value. A spin-off, should be less complicated to analyze and we feel it would appeal to a larger investor audience who, although interested in investing in the AM Industry, have little or no interest in either understanding, or investing in, our other business lines (i.e. waste destruction, DROSRITE™, PUREVAP™, amongst others), and a spin-off could help avoid this. Concurrently, we feel a spin-off would provide for a clearer, and better defined, entity, which third parties could consider for joint ventures, strategic alliances, or even an acquisition of PyroGenesis Additive.

Q. Why the delay in the spin-off?

A. Simply put: the world of AM has changed significantly since we first announced our intention to spin-off our additive manufacturing capabilities; and, may I add, all for the better for PyroGenesis’ shareholders.

Over a year ago, we announced our intention to start producing speciality powders for the AM Industry which garnered such interest that it became apparent that PyroGenesis’ shareholders might be best served by spinning off this business line.

As such, we announced our intention to spin off our AM capabilities, but while completing our analysis of the various options available, and just when we were about to make a decision, General Electric (“GE”) announced its acquisition of Arcam, in November 2016, for approximately US$700MM. Now this is noteworthy because Arcam’s subsidiary, AP&C, which was acquired by Arcam for Can$35MM in 2014(2), produced powders using PyroGenesis’ old proprietary technology under an agreement which precluded PyroGenesis from competing against AP&C until 2012. Of particular note, through Arcam, AP&C became the dominant supplier of speciality powders to the AM Industry. GE’s acquisition of Arcam, and by extension of AP&C, has effectively disrupted the supply chain of speciality powders in the AM Industry which has caused end users of such powders to re-examine their access to them, all while PyroGenesis is re-entering the market as a supplier of such powders.

It would not have been prudent for us to carry on with a spin-off merely because we announced such intentions a few months earlier, without fully analyzing the ramifications of the changing landscape.

Q. Where does the spin-off stand and what should investors expect?

A. We believe that the delays in the spin-off have essentially created more value for investors when PyroGenesis Additive is eventually spun off. We will have a working system, with dedicated employees contributing solely to the spin-off, thereby reducing risk and creating more value for PyroGenesis’ shareholders. Additionally, since GE’s acquisition of Arcam, there has been significant interest in PyroGenesis’ powder production capabilities and as such, we believe there is a high probability that we will have visibility on, if not signed, contracts for long term powder supply by the time we spin-off PyroGenesis Additive. At this point, we believe the interests of our shareholders are best served if the spin-off were concurrent with the signing of long term contracts.

Q. When could we expect the spin-off to occur?

A. Given the interest in our powders during the ramp-up phase, we are, barring any developments to the contrary, still committed to a spin-off in 2017.

Q. Speak to us about the ramp-up phase. How is it going? Where do you stand? Have there been any significant issues or developments to report?

A. We could not be happier.

We assembled and commissioned the system, and had our first powder run, as promised, by the end of 2017-Q1 despite significant delays from suppliers. Next, our goal was to ramp-up to full capacity over the ensuing four (4) months (i.e. April-July). Our stated goal was to become a leading supplier of high purity powders with an initial focus on producing commercially pure Titanium and Ti-6Al-4V powders, with additional powders/products being developed on a case by case basis. We did not expect any powder sales until ramp-up was complete however, to our surprise, on April 25, we announced having received a sample order from a multinational conglomerate. To top that off, last week we announced receipt of a second sample order, which together we believe speaks to both the confidence in our capabilities and the demand for our product in the marketplace.

These orders, although excellent news, have nonetheless put some pressure on a number of aspects relating to ramp-up; in particular, the orders we received were not only for titanium powders which we are used to producing, but as announced, also for Inconel which we had never processed before.

To make a long story short, ramp-up was put on hold in order to fulfill the order for Inconel, but the following was done successfully. In fact, the powder production rate was far greater than that for Titanium and the Inconel powder was of exceptional quality; proving, amongst other things, the flexibility of our Plasma Atomization System and how quickly we can “pivot”.

All that to say, given these orders, the ramp-up phase has been extended by approximately, 4-6 weeks.

Separately, but in parallel, PyroGenesis’ existing quality control system (ISO 9001:2008 certified) is being expanded to include the additional protocols required by the AM Industry.

Q. Could you please provide an update on the next significant milestone in powder production?

A. Most certainly. We are currently producing flowable powder batch after batch. What is even more noteworthy is the fact that, although our original ramp-up envisioned producing Ti64, we have also successfully produced Inconel powders and are currently in discussions to consider producing additional materials as well.

The next milestone is to move to a 2 shift/day, which we are currently hiring and training for. Given the natural lag that occurs during the summer, we are not expecting this to be completed before the end of August.

Q. Could you give us an indication in terms of production rate and quality of the powders at this stage of the ramp-up phase?

A. Again, we are very happy with the results so far. First and foremost, our production rate is significantly better than what we used to have. The powders already meet or exceed the ASTM specifications and we expect that by the end of the ramp-up phase our Ti64 powders will be of a significantly higher quality.

Additionally, we have adjusted the process to be Tungsten free, something it seems that various industries are interested in, and we are very happy with the results so far. We expect that by year-end, we will be able to guarantee a Tungsten free product.

Q. Any concerns?

A. Yes and no. We have definitely underestimated the interest in our production and it has become apparent that we need to expand our capacity faster than originally planned. We currently have plans to order the long lead items for 3 more systems in anticipation of having to address this need.

Separately, this early interest has caused us to think of adding in-house analytical capabilities and automated sieving processes earlier than planned. All this bodes well for the underlying business as both speak to quicker turnaround time and more reliable post production processing.

Q. In your April 25th press release you noted that you had “…signed a number of agreements with significant and potential players in the AM Industry, wherein the Company is in discussions regarding the possibility of concluding certain business relationships or transactions related to AM, most notably geared to the production of powders…”. Could you elaborate on this?

A. Yes, but in all fairness we did point out that although noteworthy, we cautioned concluding that anything of significance would happen quickly, or even at all. Discussions take time and we are still in the early phases, and that still rings true.

However, we note that we have had discussions with top level metal printer manufacturers, distributors, and end-users; some at our facilities and others at theirs. It is indeed encouraging to see that our product is having the resonance that we thought it would have in the marketplace. The minimum takeaway should be the interest we are garnering from very discerning entities in such a short time frame.

Q. So, in conclusion, you are confident?

A. Absolutely. The decision to re-enter into powder production was the right one. The changes and consolidation in the marketplace over the past year have only underscored this decision. We are the inventors of Plasma Atomization, a process that arguably has helped bring AM to where it is today, and so we can say with confidence, that we are back. We are back to producing, but more so, improving the process that has become the gold standard in the AM Industry.

Q. Your goal?

A. As previously announced, our goal is not only to become a significant producer of metal powders to the AM Industry, but to bring the technology to a new level and enable 3D printing to reach new heights by effectively making our old technology, the gold standard, obsolete. We are making great strides on both fronts, and we have only been up and running for less than 3 months.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc. is the world leader in the design, development, manufacture and commercialization of advanced plasma processes. PyroGenesis provides engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Its core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Its operations are ISO 9001:2008 certified, and have been ISO certified since 1997. PyroGenesis is a publicly-traded Canadian company on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace (Ticker Symbol: PYRNF). For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTC Markets Group Inc. accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

1 Wohlers Report 2016 (ISBN 978-0-9913332-2-6)

2http://advancedpowders.com/news/arcam-to-make-strategic-acquisition-of-metal-powder-manufacturer-to-secure-supply-of-strategic-raw-materials

Rodayna Kafal
VP, Investor Relations and Communications
(514) 937-0002
[email protected] or [email protected]

Tetra Bio-Pharma Announces UNB Cannabis Health Research Chair $TBP.ca

Posted by AGORACOM-JC at 9:26 AM on Tuesday, June 13th, 2017

Tbp large

  • Tetra Bio-Pharma Inc. and The New Brunswick Health Research Foundation are investing a combined $1 million,
  • $500,000 each over five years to establish a Health Research Chair in Cannabis at the University of New Brunswick (UNB)

OTTAWA, ONTARIO–(June 13, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF) and The New Brunswick Health Research Foundation are investing a combined $1 million, $500,000 each over five years to establish a Health Research Chair in Cannabis at the University of New Brunswick (UNB).

The chair will focus on the study of biochemistry, medicinal use and pharmacology of cannabis. This research will expand UNB’s commitment to research and innovation in the field of natural product and biomedical, health and life sciences – adding to its reputation as a leader in natural products’ research.

“The Cannabis Health Research Chair is a key example of the university’s commitment to discovery,” says Dr. David Burns, Vice-President (Research), UNB. “We believe in the power of research to advance innovation within New Brunswick. With 75 per cent of the province’s public funded research taking place at UNB, we’re thrilled to play a central role.”

Potential research areas for the chair include the analysis of existing cannabis literature, in order to understand inconsistencies and identify needs for future research; the biochemistry and medicinal chemistry analyses of cannabis; and preclinical pharmacology studies.

“Health research is instrumental in helping us find better ways to provide patient care in our province,” says Health Minister Victor Boudreau. “This new Cannabis Research Chair will certainly provide crucial and innovative information on the use of cannabis as a medical treatment.”

“We are honoured to invest with the New Brunswick Health Foundation in establishing a research chair at the University of New Brunswick as Tetra positions itself as a global leader in pharmaceutical cannabis,” said Andre Rancourt, CEO of Tetra Bio-Pharma.

The recruitment and nomination process will be conducted at the University of New Brunswick for a tenured track faculty member. Funding for the chair is expected to start in the 2017-18 fiscal year.

Dr. Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma added: “Over the past few years, the province of New Brunswick has positioned itself on the forefront as global leaders in the development of cannabis products for health care. The Tetra team has partnered with the New Brunswick Health Research Foundation to help bring innovative cannabis-based therapies to patients. We have no doubt that when established, the work of this new chair will contribute significantly to this network by providing crucial information on the safety toward implementing new cannabis based products to practitioners working to help improve the quality of life for patients specifically living with chronic pain.”

This research will expand the university’s capacity to train, mentor and prepare undergraduate and graduate students to work effectively in botanical product research.

“The present Health Research Chair, the second one announced within a month, clearly signifies New Brunswick’s intention to be at the forefront of cannabis research. This competitive Chair will further develop the science toward implementing proven and safe innovative cannabis-based therapies for the chronic treatment of various disorders (pain, PTSD, etc.),” says Dr. Bruno Battistini, President, CEO and Scientific Director of the New Brunswick Health Research Foundation.

“New Brunswick, with such entities as UNB, the NB Research and Productivity Council, and Tetra Bio-Pharma as the private sector partner, create a unique association, leveraging scientific and innovation expertise that will strongly address the clinical challenges introduced by the legalization and regulation of this natural product.”

About Tetra Bio-Pharma:

Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE: TBP) (OTCQB: TBPMF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

Source: Tetra Bio-Pharma

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
(514) 360-8040 Ext. 203
[email protected]
www.tetrabiopharma.com

 

American Creek Reports That JV Partner Tudor Gold Plans to Define a Gold Resource at Treaty Creek $AMK.ca

Posted by AGORACOM-JC at 9:35 AM on Monday, June 12th, 2017

Hublogolarge2 copy

  • JV partner and operator Tudor Gold Corp. has announced their 2017 drilling plans and confirmed that they intend to define a gold resource this summer at the Treaty Creek Project located in BC’s “Golden Triangle”
  • Primary goals to develop a primary resource estimate on the Copper Belle zone and to determine how much further drilling is required to develop a preliminary resource estimate on the GR2 zone

CARDSTON, ALBERTA–(June 12, 2017) – American Creek Resources Ltd. (TSX VENTURE:AMK) (“American Creek”) is pleased to report that JV partner and operator Tudor Gold Corp. (“Tudor”) has announced their 2017 drilling plans and confirmed that they intend to define a gold resource this summer at the Treaty Creek Project located in BC’s “Golden Triangle” immediately north of, and in the same hydrothermal system as, Seabridge Gold’s KSM project and Pretivm’s Brucejack project.

Tudor, in Friday’s news release, confirmed the main goals for the 2017 Treaty Creek program as outlined in their previous April 4, 2017 news release and stated the following:

“Two of the primary goals of the 2017 exploration program on the Treaty Creek claims are to develop a primary resource estimate on the Copper Belle zone and to determine how much further drilling is required to develop a preliminary resource estimate on the GR2 zone.

James McCrea, PGeo, has been retained to prepare the resource estimates on the Copper Belle and GR2 zones. Mr. McCrea has a wealth of experience as a geologist and resource specialist, including the preparation of resource estimates for other publicly traded companies operating in the Golden Triangle near Stewart, B.C. Mr. McCrea will supervise a drilling plan aimed at carrying out sufficient infill and stepout drilling in the Copper Belle zone to permit a resource estimate based on a 50-metre-by-50-metre drill hole spacing over a surface area of 500 metres by 300 metres. It is anticipated that all holes will be drilled to a minimum depth of 300 metres. Holes showing continuing mineralization may be drilled deeper, and, as warranted, drill casings will be left in place to facilitate further exploration. Additionally, cut channel trenching will be employed in areas where mineralization crops out on surface.

As also detailed in the press release of April 4, 2017, the 2017 drill results will be used to further interpret and validate the results of the magnetotellurics (MT) survey carried out in 2016. Through that process, the results of the MT survey will become even more useful in guiding further exploration toward expanding mineral resource estimates.

Raul Sanabria, PGeo, has designed a drilling plan for the GR2 zone which will focus on delineating the high-grade gold zone found in hole GR2-09-07 and extending the known mineralized zone along strike for 500 metres and downdip for another 500 metres.

More Core Diamond Drilling Services of Stewart, B.C., will carry out all the diamond drilling in 2017. More Core has extensive experience drilling on the Treaty Creek claims for both Tudor Gold and prior rights holders. More Core will dedicate two drill rigs to the Treaty Creek project, with drilling to commence as soon as the snowpack has melted enough to ensure safe, logistically feasible operations.”

Darren Blaney, President and CEO of American Creek stated: “We are very pleased and excited to see the Treaty Creek Project take a major step forward this summer with Tudor beginning work on developing resource estimates for both the Copper Belle and GR2 gold zones. In addition, with the 2016 MT survey indicating that mineralized zones extend towards Seabridge’s Iron Cap zone (located within 1 km of the Treaty Creek claim boundary), we will be closely watching the outcome of Seabridge’s significant 2017 drill program planned for the Deep Iron Cap zone as they follow up on their spectacular drill hole IC-16-62 from last summer.”

The Treaty Creek Project is a joint venture between Tudor, Teuton Resources Corp., and American Creek. Tudor is the operator and holds a 60% interest with both American Creek and Teuton each holding respective 20% carried interests in the property (fully carried until a production notice is given).

About American Creek

American Creek holds a strong portfolio of gold and silver properties in British Columbia. The portfolio includes three “Golden Triangle” gold/silver properties; the Treaty Creek and Electrum joint ventures with Walter Storm/Tudor as well as the recently acquired 100% owned past producing Dunwell Mine. Other properties held throughout BC include the Gold Hill, Austruck-Bonanza, Ample Goldmax, Silver Side, Red Tusk and Glitter King.

Information relating to the Corporation is available on its website at www.americancreek.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Kelvin Burton
403 752-4040
[email protected]
www.americancreek.com

AGORACOM Small Cap Wrap – All The Big Stuff In Small Cap

Posted by AGORACOM at 8:39 AM on Saturday, June 10th, 2017

ENJOY YOUR WEEKEND – WE’VE SUMMARIZED THE BEST HEADLINES FOR YOU!

Namaste Announces Record Monthly Sales of CAD$1.108M

The World’s #1 B2C E-Commerce Vaporizer Seller Is Growing Faster And Dominating The Hyper-Growth Vaping Industry.

Monarques Gold Driving Toward Production On It’s Croinor Gold Mine In Quebec

$9M Cash + $9M Gov’t Credits. Fully Permitted and Tier-1 Investors.

Peter Pascali Is Canada’s Elon Musk And PyroGenesis Is The Company You Have To Watch

His Technology Is Being Used On US Aircraft Carriers, DARPA and Multi-National Conglomerates. Yep, He’s Elon Musk 2.0

Tetra Bio-Pharma Completes Phase 1 Of First Ever Smokeable Cannabis Drug For Late-Stage Cancer Patients With Pain

Company Is Now Accelerating Path Phase III Trial, Which Is A Tremendous Accomplishment In Cannabis Pharma

AGORACOM Welcomes Great Atlantic Resources With Advanced Projects In Atlantic Canada Eh!

Not 1, Not 2 … But 7 (SEVEN) Great Properties In Atlantic Canada. We’ve Summarized Them HERE.

Have A Great Weekend!

INTERVIEW: Namaste Discusses Receiving Health Canada Medical Device Establishment Licence in Order to Distribute Approved Vaporizers $N.ca

Posted by AGORACOM-JC at 9:07 AM on Thursday, June 1st, 2017

FEATURE: Monarques Gold (TSX-V: MQR) Flagship Croinor Gold Mine Has Great Potential To Become A Producer $MQR.ca

Posted by AGORACOM-JC at 3:01 PM on Monday, May 29th, 2017

Monarquesgold hub large

Why Monarques Gold?

  • Flagship Croinor Gold Mine Has Great Potential To Become A Producer
  • Company Is Well Financed, Including $9 Million In Credits From Quebec Government
  • Recently acquired 750 ton-per-day Beacon mill
  • Major Shareholders include: Rob McEwen and Nemaska Lithium

Croinor Gold Property

Flagship project at the prefeasibility stage

  • 100% interest in the Croinor Gold property, a gold mine project that is currently at the prefeasibility stage
  • Property consists of one mining lease and two non-contiguous blocks of claims for a total of 335 claims over a 151 km² area. A 1.5% NSR is applicable on the mining lease and only 44 claims.
  • Drilling program will test a diorite-hosted gold-bearing zone that returned grades of up to 38.7 g/t Au over 3.8 metres in historical drilling (see release)

WATCH OUR CORPORATE VIDEO

Check Out Croinor Gold
Prefeasability Study

Simkar Gold Property

NI 43-101 Gold Resource 20 km from Val-d’Or

  • 100% interest in the Simkar Gold property
  • located 20 kilometres east of Val-d’Or, in the heart of the Abitibi Greenstone Belt.
  • Comprised of two mining concessions and 15 claims covering an area of 5 km², and is subject to a 1.5% NSR.
  • NI 43-101 (click here)

The Simkar Gold property is the result of a merger of the Simkar and Texsol properties. The transaction was announced by way of press release on June 26, 2014.

Regcourt Gold Property – Val d’Or

  • 100% interest in the Regcourt Gold property
  • Property is located at the eastern end of the Val-d’Or gold mining camp, some 30 km east of Val-d’Or, and is easily accessible via Route 117.
  • Consists of 94 claims covering an area of 38 km2 near the centre of the western border of Vauquelin Township
  • Property is subject to a 1.5% and 2.5 % NSR.

 

12 Month Stock Chart

INTERVIEW: Patriot 1 Technologies Discusses Superior Weapon detection Technology $PAT.ca

Posted by AGORACOM-JC at 5:49 PM on Thursday, May 25th, 2017

GGX GOLD Initiates its Market Awareness Campaign Starting June 1 2017 $GGX.ca

Posted by AGORACOM-JC at 10:48 AM on Thursday, May 25th, 2017

Ggx large

  • Company will receive significant exposure through millions of content brand insertions on the AGORACOM network and extensive search engine marketing over the next 12 months
  • Exclusive sponsorships of invaluable digital properties such as AGORACOM TV, the AGORACOM home page and the AGORACOM Twitter account will serve to significantly raise the brand awareness of the Company among small cap investors

Vancouver, British Columbia  – GGX Gold Corp. (TSXV: GGX)   (the “Company” or “GGX”)  is pleased to announce GGX Gold Launches AGORACOM Online Marketing and Awareness Program

The Company will receive significant exposure through millions of content brand insertions on the AGORACOM network and extensive search engine marketing over the next 12 months. In addition, exclusive sponsorships of invaluable digital properties such as AGORACOM TV, the AGORACOM home page and the AGORACOM Twitter account will serve to significantly raise the brand awareness of the Company among small cap investors.

Barry Brown, Director stated, GGX Gold has commenced building out its Market awareness strategy which will have several components initiating over the next month.  AGORACOM has proven to be a leader in the online marketing space. We are delighted to have retained their services to expand our online presence…”

About AGORACOM

AGORACOM is the pioneer of online investor relations, online conferences and online branding services to North American small and mid-cap public companies, with more than 250 companies served. More than just lip service, AGORACOM achieved two very big milestones on January 22, 2017, surpassing 50 Million Visits from 7 Million investors on AGORACOM.  The company also expect to surpass 500 Million page views later this year.

AGORACOM traffic ranks within the top 0.5% of all websites around the world. These traffic results are independently tracked and verified by Google analytics. AGORACOM traffic can be attributed to its strategy of maintaining the cleanest, moderated small-cap discussion as a result of implementing the first ever Investor Controlled Stock Discussion Forums.

AGORACOM Founder, George Tsiolis, publishes the leading blog on small to mid cap investor relations. His 50 Small-Cap CEO Lessons are a must read for CEO’s looking to increase their education and knowledge about online investor relations.

About GGX Gold Corp.

GGX GOLD CORP. (TSX-V: GGX) is a gold exploration company primarily focused in southern BC: The Gold Drop mine in Greenwood has permits in place for drilling and trenching. GGX’s current strategy is to prove up existing reserves and begin small scale production on the Gold Drop mine.

Shares for Services Program
The Company intends to issue shares for services to AGORACOM in exchange for the online advertising, marketing and branding services (“Advertising Services”). Pursuant to the terms of the agreement, the company will be issuing;

TERM: June 1, 2017 – June 1, 2018

FEES:  $CDN 40,000 + GST to be paid via Shares for Services over the term

  • Collateral Marketing Materials;
  • Custom HUB;
  • Advertising Modules (Banner, Skyscraper, Big Box)
  • Marketing Plan

The number of shares to be issued at the end of each period will be determined by using the closing price of the Shares of the Company on the TSX Venture Exchange on the first trading day following each period for which the Advertising Services were provided by AGORACOM.

The agreement/arrangement is subject to TSX-V approval.

The term of the Agreement is for 12 months effective June 1, 2017. The Company will issue a press release after the issuance of shares under the terms of the agreement.

On Behalf of the Board of Directors

Barry Brown, Director

604-488-3900

Forward Looking Information

This news release includes certain statements that constitute “forward-looking information” within the meaning of applicable securities law, including without limitation, the Company’s information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the completion of the proposed transactions. Forward-looking statements address future events and conditions and are necessarily based upon a number of estimates and assumptions. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “estimates” or “intends”, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved), and variations of such words, and similar expressions are not statements of historical fact and may be forward-looking statements. Forward-looking statement are necessarily based upon several factors that, if untrue, could cause the actual results, performances or achievements of the Company to be materially different from future results, performances or achievements express or implied by such statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the price of gold and other metals, anticipated costs and the ability to achieve goals, and the Company will be able to obtain required licenses and permits. While such estimates and assumptions are considered reasonable by the management of the Company, they are inherently subject to significant business, economic, competitive and regulatory uncertainties and risks including that resource exploration and development is a speculative business; that environmental laws and regulations may become more onerous; that the Company may not be able to raise additional funds when necessary; fluctuating prices of metals; the possibility that future exploration, development or mining results will not be consistent with the Company’s expectations; operating hazards and risks; and competition. There can be no assurance that economic resources will be discovered or developed at the Gold Drop Property. Accordingly, actual results may differ materially from those currently anticipated in such statements. Factors that could cause actual results to differ materially from those in forward looking statements include continued availability of capital and financing and general economic, market or business conditions, the loss of key directors, employees, advisors or consultants, equipment failures, litigation, competition, fees charged by service providers and failure of counterparties to perform their contractual obligations. Investors are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. The forward-looking statements included in this news release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities legislation.

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tetra Bio-Pharma Files Patent for the Treatment of Cancer and Ocular Disease $TBP.ca

Posted by AGORACOM-JC at 4:17 PM on Wednesday, May 17th, 2017

Tbp large

  • Submitted a provisional patent application with the U.S. patent and trademark office for a pharmaceutical drug formulation to treat various forms of cancer and ocular disease
  • Global market for cancer drugs has hit US$100 billion in annual sales
  • Could reach US$147 billion by 2018, according to a new report by IMS Institute for Healthcare Informatics

OTTAWA, ONTARIO–(May 17, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:GRPOF), today announced that Tetra has submitted a provisional patent application with the U.S. patent and trademark office for a pharmaceutical drug formulation to treat various forms of cancer and ocular disease.

The global market for cancer drugs has hit US$100 billion in annual sales, and could reach US$147 billion by 2018, according to a new report by the IMS Institute for Healthcare Informatics. According to Transparency Market Research, the global ophthalmic drug market is expected to reach US$21.6 billion by 2018 due to high incidence of eye-related disorders amongst geriatrics. The provisional patent aims to protect new pharmaceutical combinations of cannabinoids and terpenoids to inhibit a specific signaling pathway, known as Hedgehog (Hh), and their use to combat human diseases.

“Filing of this provisional patent marks the launch of an innovative and exciting project that could not only impact patients suffering from a variety of human diseases, but also further Tetra’s interests in developing and commercializing novel cannabinoid-based pharmaceutical drugs,” said Dr. Guy Chamberland, Chief Scientific Officer of Tetra. “The rationale forming the basis for this project is well founded and our research team has extensive scientific experience in the Hh field. We look forward to quickly advancing the project through key academic collaborations, with the ultimate goal of developing multiple pharmaceutical treatments.”

Background Information:

Hh signaling is a critical developmental molecular signaling pathway and inappropriate over activation of Hh is causal in several types of human tumors, including medulloblastoma, basal cell carcinoma, rhabdomyosarcoma, and multiple forms of leukemia, as well as liver, stomach, small cell lung, prostate, and breast cancers. Hh signaling also regulates the formation and remodeling of blood vessels, and aberrant blood vessel growth is implicated in several human diseases. The eye is particularly vulnerable to dysfunctional angiogenesis and neovascularization, such as in the case of diabetic retinopathy, age-related macular degeneration, neovascular glaucoma, retinal vein occlusion and retinopathy of prematurity, where inappropriate ocular blood vessel growth often leads to irreversible blindness if left untreated.

Currently, there are few clinically approved treatments for Hh-pathway-dependent cancers and drug resistance remains a major hurdle. As well, current treatment approaches to neovascular and angiogenic ocular disease are insufficiently effective and have significant adverse effects. Thus, there is a large need to develop novel therapies to treat human cancers and ocular disease related to blood vessel growth. Recently, cannabinoids have emerged as novel and potent inhibitors of the Hh signaling pathway and terpenoids have been shown to modulate the effects of cannabinoids through an undefined mechanism. Tetra looks to capitalize on these recent findings by filing a provisional patent for the use of cannabinoids in combination with terpenoids to treat Hh related cancer growth and aberrant blood vessel growth in the eye. Securing a provisional patent and achieving the freedom to operate is an important first step in the realization of this project.

About Tetra-Bio Pharma:

Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP)(OTCQB:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
(514) 360-8040 Ext. 203
[email protected]

FEATURE: Grizzly (GZD-TSX-V) – More than 9M oz of gold produced or as resources nearby $GZD.ca

Posted by AGORACOM-JC at 11:52 AM on Wednesday, May 17th, 2017

Gzdnew

WHY GRIZZLY DISCOVERIES?

  • World class gold and base metal deposits in British Columbia; and diamonds in Alberta.
  • More than 9 million oz Au produced or as resources in a radius of less than 70KM to Greenwood project
  • Holds, or has an interest in, metallic and industrial mineral permits for potash totalling more than 364,000 acres along the Alberta-Saskatchewan border
  • Four precious-base metal properties in British Columbia totalling over 235,000 acres. Grizzly also currently holds more than 231,000 acres in diamond properties, which host diamondiferous kimberlites in the Buffalo Head Hills and Birch Mountains of Alberta
  • Portions of Grizzly’s Greenwood Project being explored by Kinross through option agreement

EXPLORATION HIGHLIGHTS

  • Drillholes with up to 31.1% K2O results from assays on recent Grizzly drill program
  • Historic Unity Potash Mine 45 km east of existing GZD lands
  • Agrium Vanscory Potash Mine 200 km east of GZD lands
  • Significant Potash in drill core or indicated by gamma logs at depths ranging from 1,060m to 1,675m
  • Temperatures at those depths range from about 50oC to 75oC. Optimal temperature for solution mining is approximately 75oC.

POTASH DEMAND AND GROWTH

  • According to industry estimates, Canada has Potash resources of 7.3 billion tonnes – roughly 52% of the world’s supply.
  • Currently 11 mines in Saskatchewan produce the majority of Canada’s 35% contribution to the world’s annual production.
  • The arable land per person in the world is declining, and weather patterns are becoming more volatile and extreme, fuelling demand for Potash which increases the yield per acre approximately 40%.

BC PRECIOUS METALS

Greenwood Gold District

Portions of Grizzly’s Greenwood Project being explored by Kinross is 100% owned by Grizzly Discoveries Inc. and includes 131 claims that form a contiguous package totaling approximately 27,346 hectares, representing approximately one third of Grizzly’s land holdings at Greenwood. Under the terms of a September 2015 agreement, KG Exploration (Canada) Inc. can earn a 75% interest on the optioned land pursuant to an Option Agreement with Grizzly on portions of its land holdings in southeastern British Columbia by incurring US$3 million in exploration expenditures over a 5 year period. By the second anniversary of the agreement, 750 metres of diamond drilling must be completed along with US$750,000 in expenditures by September 23, 2017.

 ALBERTA DIAMONDS

  • Following 12 drill holes, 3 new diamond bearing kimberlites were discovered in 2008 at the Buffalo Head Hills property.
  • Grizzly has more than 200,000 acres surrounding Diamondex & Shore Gold in the Buffalo Head Hills.
  • Two kimberlite pipes look very promising and need bulk sampling which is being planned for future dates due to Grizzly’s current potash focus.
  • Land rights are valid for 2 to 5 years based on existing development work done on properties by Grizzly.

Buffalo Head Hills Diamond Property, Alberta
A Renewed Interest in diamonds

Renewed interest in diamond exploration during 2015 and 2016 has prompted re-evaluation of Grizzly’s Buffalo Head Hills Diamond Project in north-central Alberta, which is located approximately 330 kilometres northwest of Edmonton and is easily accessed during summer and winter by a large network of roads and cutlines. Based upon an internal review of all data, the Company has staked additional permits of highly prospective lands for diamond-bearing kimberlites in the Buffalo Head Hills area. Grizzly’s total land position includes 11 permits that encompass approximately 220,000 acres.

Check Out Our Recent Fact Sheet

12 MONTH STOCK CHART